Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History $8.89 -0.01 (-0.11%) Closing price 04:00 PM EasternExtended Trading$8.79 -0.10 (-1.17%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cyclacel Pharmaceuticals Stock Price Performance The Cyclacel Pharmaceuticals (CYCC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 97.45%, with a year-to-date return of -90.15%. In the past month, the stock has increased 168.58%, reflecting recent market activity. As of the latest close, Cyclacel Pharmaceuticals traded at $8.90 with a market cap of $14.06 million and volume of 65,785 shares. Five years ago, the stock traded at a split-adjusted price of $16,164.00, representing a 99.95% decrease over that period. At the time, it had a market cap of $22.70 million and a volume of 1 shares. Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.25%1 Month Performance+168.58%3 Month Performance-74.45%Year-To-Date Performance-90.15%1 Year Performance-97.45%5 Year Performance-99.95% CYCC Stock Chart for Thursday, August, 14, 2025 CYCC Chart by TradingView Cyclacel Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$8.90$8.89-0.11%$8.92$8.1390,286 shs$14.09 million08/13/2025$9.28$8.90-4.09%$9.52$8.8165,785 shs$14.06 million08/12/2025$9.05$9.28+2.54%$9.45$8.9585,341 shs$14.66 million08/11/2025$8.78$9.05+3.08%$9.53$8.67126,328 shs$14.34 million08/08/2025$8.97$8.78-2.12%$10.08$8.70227,767 shs$13.92 million08/07/2025$7.41$8.97+21.05%$9.77$7.45458,368 shs$14.17 million08/06/2025$8.21$7.41-9.74%$7.91$7.21179,311 shs$11.71 million08/05/2025$9.81$8.21-16.31%$10.58$7.911.60 million shs$13.01 million08/04/2025$9.72$9.81+0.93%$10.07$9.2874,806 shs$15.50 million08/01/2025$11.21$9.72-13.29%$10.93$9.50145,070 shs$15.36 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$12.39$11.21-9.52%$12.25$11.16111,586 shs$17.71 million07/30/2025$13.25$12.39-6.49%$14.15$12.20151,972 shs$19.64 million07/29/2025$15.39$13.25-13.91%$15.03$12.28249,240 shs$20.94 million07/28/2025$16.04$15.39-4.05%$16.28$14.69194,106 shs$24.32 million07/25/2025$17.15$16.04-6.47%$18.00$15.54459,589 shs$25.34 million07/24/2025$14.00$17.15+22.50%$19.87$15.206.19 million shs$27.18 million07/23/2025$10.76$14.00+30.11%$15.48$10.801.72 million shs$22.12 million07/22/2025$11.66$10.76-7.72%$13.39$10.05344,686 shs$17.00 million07/21/2025$13.07$11.66-10.79%$14.37$11.32974,176 shs$18.48 million07/18/2025$8.23$13.07+58.81%$18.00$8.0022.29 million shs$20.65 million07/17/2025$8.20$8.23+0.37%$9.48$7.761.31 million shs$13.05 million07/16/2025$12.33$8.20-33.50%$10.28$7.513.53 million shs$12.96 million07/15/2025$3.31$12.33+272.51%$19.25$4.5563.34 million shs$19.54 million07/14/2025$3.71$3.31-10.78%$3.65$3.27134,768 shs$5.25 million Related Companies INmune Bio Stock Chart Biomea Fusion Stock Chart MiNK Therapeutics Stock Chart InflaRx Stock Chart DURECT Stock Chart Barinthus Biotherapeutics Stock Chart Cue Biopharma Stock Chart PyroGenesis Canada Stock Chart ImmuCell Stock Chart Adlai Nortye Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access